TeicoplaninImmuneSafety Rating 8/10
Primary research areaGram-positive bacterial infections (not US approved)
Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.
Research dose range400-800 mg loading then 200-400 mg daily IV/IM
AdministrationIV or IM injection
Safety8/10 · Approved (EU/international)
NCAA D1Permitted
Price Comparison
Compare vendors
No vendor pricing available for this peptide yet.
Overview
About Teicoplanin
Mechanism of action
Glycopeptide antibiotic similar to vancomycin; inhibits cell wall peptidoglycan synthesis
Safety profile
Nephrotoxicity, ototoxicity, hypersensitivity reactions; not FDA approved · Well-established glycopeptide; nephro/ototoxicity monitoring; similar to vancomycin profile
🔔 Get notified when the price drops anywhere
No account required. We scan 30+ vendors daily — one email the moment any vendor drops Teicoplanin below your target.
Related pages